November 1, 2023, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has partnered with a US-based biotech to lead all clinical trial management activities of their Phase Ib Dose Escalation followed by Phase II randomized, placebo controlled, blinded end-point trial in patients with Acute Respiratory Distress Syndrome (ARDS), including COVID-19 patients. The dose escalation phase of the study will inform the safety profile of the Sponsor’s Investigat...

Vantage BioTrials’ President, Vatche Bartekian, was recently interviewed by Pharmaboardroom on ways that the company focuses on operational excellence with a lean and holistic approach to each project and how they continually advocate for greater visibility for Canada on the international stage and an increase in collaboration within the pharmaceutical industry and regulatory bodies. “What we can observe in Canada is a very diverse CRO landscape, in which each player has found its ow...

The future of clinical research after COVID-19 How will this crisis affect the clinical trial industry in Quebec? Just like in other industries, this pandemic, unfortunately, had an immediate impact on the pharmaceutical industry and notably clinical trials. The multiple restrictions limiting physical interactions between people entails many challenges and a multitude of projects that have been curtailed, postponed or even canceled. In the past weeks, we have observed four major problems linked...

April 24, 2023, Montréal, Canada – Long before the COVID-19 pandemic, Vantage BioTrials had established the need to virtualize and offer its employees flexibility by offering remote working conditions. As a niche CRO, we believe in making a difference by striving to find better ways to reduce our carbon footprint, be productive and more efficient. By going virtual, we are achieving the following benefits: Reducing Waste and Carbon Footprint: We have digitized all SOPs and Policies and as a r...

July 18, 2022, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has on-boarded a robust technology solution to manage its growing demand of early/late phase and medical device clinical trials. Accuracy, flexibility, and speed in obtaining real-time data are crucial. During the last couple of years of the Covid-19 pandemic, Vantage BioTrials remained focused in identifying areas of development that will add value to the overall maintenance, tracking a...

  August 30, 2021, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), is proud to have successfully managed, and completed approximately 12 months in advance, a Phase IV observational, multicentre, postmarketing study in adult patients with a clinical diagnosis of moderate-to-severe Hidradenitis suppurativa (HS). The primary objective of this clinical trial was to measure real-world effectiveness of adalimumab in HS and to secondarily observe cli...

August 27, 2020, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), has partnered with its biotech Sponsor, Laurent Pharmaceuticals, to lead all clinical trial management activities of their lead oral drug candidate LAU-7b in a multicentric Phase 2 placebo-controlled clinical trial (RESOLUTION) in patients with COVID-19. We are pleased to join Laurent Pharmaceuticals in announcing that approval has been received from the Food and Drug Administration (F...

Post Marketing Observational Epidemiological Study: Assessing Drug’s Real-life Effectiveness and Impact on Rare Dermatological Indication Burden of Illness and Health Care Resources Utilization MONTREAL, February 19, 2020 – Vantage BioTrials was appointed by its Pharmaceutical Sponsor to manage their Phase IV Post Market Observational Epidemiological clinical trial in a rare dermatological disease. The set enrollment expectation by the Pharmaceutical Sponsor was to recruit 145 patients a...

MONTREAL, February 7, 2019 – Vantage BioTrials is a full-service Contract Research Organization (CRO) based in Canada that provides Phase I-IV clinical trial management services to pharmaceutical, biotechnology & medical device companies. Since inception, Vantage BioTrials has been providing Phase I-IV clinical trial management services to pharmaceutical, biotechnology & medical device companies, along with operational capabilities across North America, Latin America, and Europe. Van...

January 7, 2019, Montreal, Canada – Earlier this year, Vantage BioTrials (VBT) took a very important step forward by volunteering to take part in the first of its kind Health Canada pilot inspection program. The program focused on VBT’s internal processes, procedures & protocol specific studies. “Through our dedication & transparency for adhering to quality principles, we continue to add tangible credibility towards achieving operational excellence for our clients, pati...